Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Valeant makes hedge fund-assisted play for Allergan

22.04.2014 / Scripintelligence

An acquisition of Allergan by Valeant, which could be valued at substantially more than $40bn given Allergan's current market cap, makes a lot of sense. Both companies have heavy interests in dermatology and ophthalmology, but Valeant chairman and CEO…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: